Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | DHFR | P00374 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10335441 | 0.86 | LMNA (0.53) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL7142492 | 0.84 | TSHR (0.53) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL6706308 | 0.84 | TSHR (0.63) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL31236972 | 0.82 | PTPN1 (0.54) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL3661269 | 0.82 | THRA (0.52) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL21098685 | 0.81 | CYSLTR2 (0.53) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL120379 | 0.81 | DHFR (0.48) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL29402124 | 0.81 | DHFR (0.48) | FFAR1FFAR4TSHRDHFRPPARA | |
| SCHEMBL9782939 | 0.81 | THRA (0.46) | TSHRLMNA | |
| SCHEMBL8355715 | 0.81 | PPARA (0.56) | FFAR1DHFRPPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040265949-A1 | Method and building blocks for preparing C-terminally labelled peptides | MERCK PATENT GMBH (DE) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040265949-A1 | Method and building blocks for preparing C-terminally labelled peptides | GLUL, DNPEP, NGLY1 | FFAR1 3898/4885FFAR4 3857/4885TSHR 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.